#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal atresia Systemic candida Philadelphia positive chronic myeloid leukaemia Vascular calcification Dupuytren's contracture Heavy menstrual bleeding HER2 gene amplification Brain stem glioma IgA nephropathy Leukoencephalopathy Hereditary angioedema Hypochromic anaemia Anti-HLA antibody test positive Rett syndrome Retinal dystrophy More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Life with Disease Leiomyosarcoma recurrent Fabry’s disease Paraneoplastic neurological syndrome – Basic Information Pemphigus Loeys-Dietz syndrome – Treatment Alternating hemiplegia of childhood – Life with Disease Synovial sarcoma metastatic – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Treatment Glomerulonephritis membranoproliferative – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    NADOFARAGENE FIRADENOVEC Fosaprepitant Autologous Microfat Lixisenatide Salbutamol A24110He VAMIFEPORT TRIHYDROCHLORIDE Ofloxacin Hydrochloride BI-1607 Daratumumab Dexamethasone Sodium Phosphate Mk-6194 Tovinontrine Pristinamycin RP3 Ondansetron Phleum Pratense Pollen Extract Leriglitazone Thymalfasin Afm24 More therapies…

    Learn about Your Condition

    Niemann-Pick disease Cervix carcinoma stage II Connective tissue disorder Glioblastoma Benign renal neoplasm Phenylketonuria Graft versus host disease Abdominal wall pain Acute respiratory failure B-cell type acute leukaemia Appendicitis Agitation postoperative Hodgkin's disease Meniere's disease Cough More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic sclerosis pulmonary

  • Study of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Systemic sclerosis pulmonary
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Rituximab
    France

  • Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • CC-97540
    • Fludarabine Phosphate
    • Nintedanib
    Belgium France Germany Italy Spain

  • Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic sclerosis pulmonary
    Investigated Drugs:
    • Tulisokibart
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic sclerosis pulmonary
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Vixarelimab
    Belgium France Germany Greece Hungary Italy +2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!